AT1R antagonists have also been shown to decrease AST levels and inhibit hepatic stellate cell activation, oxidative stress, transforming growth factor beta 1 expression, and hepatic fibrosis [42]. The gene discussed is TGFB1; the disease is Hepatic fibrosis.